Covid-19, Aifa autorizza vaccino bivalente per le varianti Omicron BA.4 e BA .5
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
Moderna seeks FDA nod for booster shot aimed at Omicron BA.4, BA.5 | Reuters
First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine
Updated Covid-19 boosters offer protection, but new studies suggest they don't offer an edge against Omicron | CNN
Moderna su LinkedIn: Moderna's Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214… | 13 commenti
Fall COVID Booster Campaign Save Thousands Lives, Billions Dollars | Commonwealth Fund
Bivalent COVID Shots May Hold Up Better Against Severe Omicron | MedPage Today
Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine
Five things we've learned about the BA.4 and BA.5 Omicron variants | Gavi, the Vaccine Alliance
Antibody Response to Omicron BA.4–BA.5 Bivalent Booster | NEJM
What's the risk if I wait for an updated bivalent COVID booster?
FDA authorizes updated COVID-19 boosters for kids under 5 - ABC News
Covid: Aifa approva il vaccino bivalente Comirnaty sviluppato contro Omicron 4-5 | Sanità24 - Il Sole 24 Ore
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice | Science Immunology
Omicron BA.4/BA.5-adapted bivalent vaccine generates higher antibody response - Hospital Pharmacy EuropeHospital Pharmacy Europe
Via libera dell'Aifa al vaccino Pfizer adattato contro le varianti Omicron 4 e 5
Richiamo Vaccino varianti Omicron BA.4-5 per bimbi da 5 a 11 anni - ASL Medio Campidano
CDC on X: "The updated #COVID19 booster can both help restore protection that has waned since the previous vaccination and provide broader protection against newer BA.4 and BA.5 Omicron subvariants. Learn more:
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine | Australian Government Department of Health and Aged Care
Updated COVID booster tied to strong Omicron immune response | CIDRAP
News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut
Health Canada approves Moderna's COVID-19 vaccine for Omicron BA.4/BA.5 variants | CBC News
EU regulator backs Pfizer/BioNTech BA.4/5-adapted COVID booster | Reuters
